Ledger.Open graph →

SEC Form D · Amendment · filed March 4, 2014

Neos Therapeutics, Inc

Offering

$15.5M

Sold

$15.5M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

GRAND PRAIRIE, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Mark J. Tengler · Grand Prairie, TXExec Greg J. Robitaille · Grand Prairie, TXDirector Dorothy J. Engelking · Grand Prairie, TXExec Victor J. Miller · Grand Prairie, TXExec Stacie J. Switzer · Grand Prairie, TXExec Arlen J. Ewart · Grand Prairie, TXExec Ralph J. Iannelli · Grand Prairie, TXDirector Carolyn J. Sikes · Grand Prairie, TXExec Asif J. Mughal · Grand Prairie, TXExec Ellen J. Hoffing · Grand Prairie, TXExec Russ J. Mcmahen · Grand Prairie, TXExec Alan Heller · Grand Prairie, TXDirector Margaret J. Cabano · Grand Prairie, TXExec Edward J. Schnipper · Grand Prairie, TXDirector Bryant Fong · Grand Prairie, TXDirector Vipin Garg · Grand Prairie, TXDirector Daniel I. Malina · Louisville, KYExec Akira J. Okubo · Louisville, KYDirector Joseph J. Dooley · Louisville, KYDirector Gayle B. Dixon · Charleston, SCExec Lindsey W. Cooper Jr · Charleston, SCExec Mark Spindel · Washington, Washington, D.C.Director Evan Burtton · Grand Cayman, Cayman IslandsExec Michael E. Marks · Menlo Park, CADirector Thomas J. Smach · Menlo Park, CAExec Michael A. Austin · Dallas, TXDirector Mark E. Davis · La Jolla, CAExec Frank E. Mccormick · La Jolla, CAExec P. K. Hawryluk · La Jolla, CAExec Troy Wilson · La Jolla, CAExec Tripp Baird · SAN FRANCISCO, CAExec Thomas D. Roberts · Fairfax, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗